Ex-Suntory chairman referred to prosecutors over supplement imports

Former Suntory Holdings chairman Takeshi Niinami has been referred to prosecutors without arrest, along with a female acquaintance, over allegations of importing illegal supplements. Investigative sources said the supplements from the United States contained prohibited levels of THC, a cannabis-derived substance. Niinami denies the allegations.

Investigative sources said that on Thursday, former Suntory Holdings Ltd chairman Takeshi Niinami and a female acquaintance had their case referred to prosecutors without arrest for allegedly importing illegal supplements. The supplements reportedly contained prohibited levels of tetrahydrocannabinol, known as THC. Niinami denies the allegation, and prosecutors are expected to carefully examine whether to pursue criminal charges.

Niinami resigned as Suntory chairman and as head of the Japan Association of Corporate Executives, known as Keizai Doyukai, last September. At a press conference that month before his Keizai Doyukai resignation, he said, "I have not broken any laws and am innocent," adding, "I have not possessed or used (the supplements) in Japan, and I did not instruct their imports."

The woman sent the supplements from the United States to her brother in Fukuoka Prefecture, who was arrested by Fukuoka prefectural police on suspicion of violating the special narcotics law. He was quoted as saying, "I was asked to send them to Niinami." Last August, Fukuoka police searched Niinami's house in Tokyo based on information from customs authorities in southwestern Japan, but found no illegal drugs. Niinami also tested negative in a urine test.

Verwandte Artikel

Tokyo Stock Exchange traders celebrate as Nikkei 225 surpasses 58,000 amid expectations for PM Sanae Takaichi's economic stimulus policies.
Bild generiert von KI

Japan's Nikkei breaks 58,000 on Takaichi policy expectations

Von KI berichtet Bild generiert von KI

Japan's Nikkei average surpassed 58,000 for the first time following the Liberal Democratic Party's landslide election victory. Expectations for Prime Minister Sanae Takaichi's economic stimulus measures are driving the market, though fiscal concerns linger.

A professor at the University of Tokyo's Graduate School of Medicine has been arrested on suspicion of accepting bribes related to a joint research project. Shinichi Sato, 62, allegedly received entertainment worth about ¥1.8 million from March 2023 to August 2024 in exchange for favors on the project involving plant cannabinoids. Police are also investigating the association representative and a former associate professor involved.

Von KI berichtet

A New York court sentenced a Japanese man, a member of a yakuza crime group, to 20 years in prison for trafficking nuclear material, drugs, and weapons. Takeshi Ebisawa, 61, had pleaded guilty to six charges in January 2025. The ruling follows years of investigations by the U.S. Drug Enforcement Administration.

The University of Tokyo apologized on Wednesday for a series of corruption cases involving faculty at its medical school and affiliated hospital. President Teruo Fujii expressed deep regret for undermining societal trust and announced the dismissal of Professor Shinichi Sato from the Graduate School of Medicine.

Von KI berichtet

Ryutaro Hatsuki, a 25-year-old infielder for the Hiroshima Toyo Carp, has been arrested on suspicion of using etomidate, a designated drug known as the 'zombie cigarette.' Hatsuki denies the allegation, claiming he has no memory of using it. The team issued an apology and pledged full cooperation with authorities.

Prosecutors raided the Seoul office of Daishin Securities on Tuesday over suspicions of stock price manipulation involving a company executive. The high-ranking official is accused of colluding with a price-rigging ring to manipulate a KOSDAQ-listed company's stock early last year. The brokerage reported the suspect to police following an internal audit and is fully cooperating with authorities.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen